Last Posted: Dec 06, 2019
- Progress Toward Precision Medicine in Frontline Treatment of Metastatic Renal Cell Carcinoma.
Singla Nirmish et al. JAMA oncology 2019 Dec - Are providers prepared for genomic medicine: interpretation of Direct-to-Consumer genetic testing (DTC-GT) results and genetic self-efficacy by medical professionals.
McGrath Scott P et al. BMC health services research 2019 Nov 19(1) 844 - Clinical Practice Settings vs Clinical Trials: Is Artificial Intelligence the Answer?
Jampol Lee Merrill et al. JAMA ophthalmology 2019 Nov - Personalized, Precision, and <i>N</i>-of-One Medicine: A Clarification of Terminology and Concepts.
Huang Sui et al. Perspectives in biology and medicine 2019 62(4) 617-639 - An update on: molecular genetics of high-risk chronic lymphocytic leukemia.
Moia Riccardo et al. Expert review of hematology 2019 Nov 1-8 - Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma.
Ishikawa Marin et al. Medical oncology (Northwood, London, England) 2019 Nov 37(1) 10 - Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma.
Brunet Maxime et al. Frontiers in oncology 2019 91204 - Revisiting the Genomic and Transcriptomic Landscapes From Female Malignancies Could Provide Molecular Markers and Targets for Precision Medicine.
Taniguchi-Ponciano Keiko et al. Archives of medical research 2019 Nov 50(7) 428-436 - Translational Informatics for Parkinson's Disease: from Big Biomedical Data to Small Actionable Alterations.
Shen Bairong et al. Genomics, proteomics & bioinformatics 2019 Nov - Precision public health emerging as a discipline
JK COhen, Modern Healthcare, November 30, 2019
.png)
No hay comentarios:
Publicar un comentario